RALEIGH, N.C., Jan. 4, 2011 (GLOBE NEWSWIRE) -- On December 28, 2010, DARA BioSciences, Inc. (the “Company”) (Nasdaq:DARA) announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.
